OnKure Therapeutics, Inc. (NASDAQ:OKUR) Receives Consensus Recommendation of “Buy” from Analysts
Shares of OnKure Therapeutics, Inc. (NASDAQ:OKUR – Get Free Report) have earned a consensus recommendation of “Buy” from the six analysts that are currently covering the firm, Marketbeat Ratings reports. Four research analysts have rated the stock with a buy recommendation and two have issued a strong buy recommendation on the company. The average 1-year […]
Shares of OnKure Therapeutics, Inc. (NASDAQ:OKUR – Get Free Report) have earned a consensus recommendation of “Buy” from the six analysts that are currently covering the firm, Marketbeat Ratings reports. Four research analysts have rated the stock with a buy recommendation and two have issued a strong buy recommendation on the company. The average 1-year […]
